Abstract

We have used a recently developed enzyme immunoassay to evaluate the prevalence of hepatitis C virus antibodies (anti-HCV) in patient groups and hospital personnel. The prevalence of anti-HCV in haemophiliacs, intravenous drug users, male homosexuals, and haemodialysis patients was 86, 63, 28, and 9 percent, respectively. Eight of 738 (1.1 percent) sera from health care workers were positive for anti-HCV. Only two of the 8 employees which were seropositive for anti-HCV also demonstrated serological markers of a previous infection with hepatitis B virus. The reported seroepidemiological data may not correctly reflect the risk of HCV transmission in the hospital setting, since the currently available assay shows a high sensitivity only for the detection of persistent HCV infections. There is an urgent need for the development of HCV antibody assays with increased sensitivity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call